Background Leptin and Isl-1 have functions to regulate the insulin secretion, but the interaction between Leptin and Isl-1 remains unknown. Results Isl-1 mediates the signaling pathway of leptin affecting insulin secretion. Conclusion Isl-1 and STAT3 are the keynote proteins linking the leptin and insulin signaling networks. Significance These findings are crucial for understanding the mechanisms of insulin secretion and metabolism.
INTRODUCTION
Insulin is a key hormone in regulating glucose metabolism. Abnormalities of insulin secretion are causal or associated with many diseases, including type 2 diabetes (1), the incidence of which is increasing worldwide due to the epidemic of obesity. The regulation of insulin secretion has been studied extensively in both normal and disease states such as diabetes and obesity using in vivo and in vitro systems (2), which have confirmed that insulin secretion is highly regulated by extrinsic and intrinsic factors, such as leptin (3-6) and LIM-homeodomain transcriptional factor Isl-1 (7). However, interactions among the extrinsic and intrinsic factors and related cellular and molecular mechanisms modulating insulin secretion still need to be elucidated, and may lead to the further understating of the pathogenesis and pathophysiology as well as novel therapeutic strategies for type 2 diabetes.
Leptin plays a fundamental role in control of satiety and body weight by acting at the hypothalamus (8). In addition, there are evidence that peripheral leptin regulates insulin secretion in pancreatic beta cells by directly acting on the ATP-sensitive potassium channels and hyperpolarizing the beta cell (4). Leptin also lowers the intracellular free calcium concentration ([Ca 2+ ]i) of pancreatic beta cell (4). In addition, leptin has been shown to act through its full-length receptor (OBRb), activate the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway in pancreatic islets (9). The activation of OBRb induces JAK-STAT3, which is implicated in transcriptional modulation (10). Besides, disruption of leptin receptors (OBRs) expression directly affects beta cell growth and function in mice (11). However, the interplay among the downstream signaling molecules, such as STATs, and intrinsic transcription factors in beta cell are still not well understood.
Insulin secretion is regulated by a variety of transcription factors in pancreatic beta cell (12), such as Pax4 (13), Nkx6.1 (14-15), Maf (16-17), Foxa (18), Pdx1 (19-20) and LIM-homeodomain transcription factor Isl-1 (7), most of which are required for pancreatic development and cell functions (21-25). A genetic study of a morbidly obese human population suggests that Isl-1 is associated with type 2 diabetes (26). However, the factors affecting Isl-1 expression and their relation to insulin secretion require further investigation.
The present study is thus designed to answer if the effect of leptin on insulin secretion is mediated by Isl-1, and identify whether there is crosstalk between leptin signaling molecules and Isl-1. In addition, we investigate whether insulin has feedback regulation on Isl-1 expression. Our in vivo and in vitro results firstly prove that leptin significantly inhibits Isl-1 and insulin gene expressions and insulin secretion, and these effects are lost in db/db mice and Isl-1 IKO mice. In addition, our findings demonstrate that Isl-1 acts as a direct downstream target of leptin signaling molecule STAT3 to influence the effect of leptin on insulin secretion, and insulin has feedback regulating effect on Isl-1 expression through JAK-STAT3 signaling pathway. These findings are crucial for understanding the mechanisms regulating insulin secretion and metabolism in related diseases, such as obesity and type 2 diabetes.
EXPERIMENTAL PROCEDURES
Animals and Tissue Preparation-Adult male mice (6-8 weeks) used for this study were approved by the Chinese Association for Laboratory Animal Sciences. In order to study the effect of the global serum leptin on Isl-1 expression, adult male mice were randomly divided into the high-fat diet (HFD), the regular grain diet control and fasted mice (n≥6 for each group) as previous report (27-28), the HFD and control groups were fed 24 h, and the fasted group was starved for 24 h. The procedures for blood and tissue collections were similar to our previous report (29 ) .
Transgenic mice-The db/db mice used were C57BL/KsJ-db+/+m congenic strain from the Jackson Laboratories. Plasmid DNA constructs-The -410 bp regions of insulin promoter gene and the Isl-1 gene promoter from -1262 to -1143 bp were amplified from rat and mouse genomic DNA respectively by PCR using specific primers in Table 1 . These fragments were respectively inserted into the pGL3.0 luciferase reporter vector (Promega, Madison, WI, USA). The murine Isl-1 pXJ40-Myc-Isl-1 vector was kindly provided by Dr. Cao X (Institute of Molecular and Cell Biology, Singapore).
Chromatin immunoprecipitation (ChIP)-EZ-ChIP
Chromatin Immunoprecipitation Kit and a nonspecific IgG antibody were from Millipore, a mouse anti-P-STAT3 antibody was from Cell Signaling Technology. The ChIP experiment was performed as our report (29). Input and immunoprecipitated DNA were amplified by PCR using primers listed in Table 1 . Immunoprecipitated DNA was amplified using SYBR green dye on a 7500 Real-Time PCR Detection System, and real-time PCR products quantified by comparison with the PCR products of a dilution series of relevant input DNA.
Luc assays-The STAT3C (Addgene, Cambridge, MA, USA) expression vector was respectively cotransfected with Isl-1 luciferase reporter vector and pTK-Ranilla vector (Promega, Madison, WI, USA) into 293T cells and NIT cells, and the Isl-1 expression vector and insulin luciferase reporter vector were cotransfected into 293T cells and NIT cells. The methods of the vector transfection and Luciferase activity detection were performed as our report (29).
Radioimmunoassay-The insulin radioimmunoassay reagents were provided by the Beijing North Institute Biological Technology (Beijing, China). For each radioimmunoassay the intra-and interassay coefficients of variation were less than 10% and 15% respectively.
Real-time PCR (RT-PCR) and common PCRReal-time PCR and common PCR were performed as described previously (29). All RNA extractions were treated with RNase-Free DNase 1 (Promega, Madison, WI, USA) for 1 h at 37 ℃. Leptin short-length receptor (OBRa) and OBRb were detected by PCR using primers in Table 1 as described in a previous study (33). For normalization purposes, an identical set of reactions was prepared for GAPDH (Table 1) .
Immunofluorescence-The immunofluorescence of pancreas sections and NIT cells were performed using methods described earlier (29). Antibodies against OBRa, OBRb and Isl-1 were from R&D, anti-insulin antibody was from Invitrogen. Biotinylated goat anti-rabbit IgG and goat anti-mouse IgG were from Zymed Laboratories, biotinylated donkey anti-goat IgG was from Sigma-Aldrich. Fluorescein isothiocyanate and tetraethyl rhodamine isothiocyanate-conjugated streptavidin were from Southern Biotech.
Western blot analysis-Protein samples extracted from pancreas or cell lysates were subjected to SDS-PAGE and immunoblotting as described in our previous report (29). Antibodies against p-ERK1/2, ERK1/2, p-STAT3 and STAT3 were from Cell Signaling Technology. Anti-Isl-1 antibody was from R&D, anti-GAPDH antibody was from Ambion. Alkaline phosphatase-conjugated goat anti-rabbit IgG and goat anti-mouse IgG were from Zymed Laboratories.
Statistical analysis-All data were analyzed using a one-way factorial analysis of variance (ANOVA), followed by Student's t test. The values were presented as the means ± S.D. of 3 independent experiments. A value of P<0.05 was considered to be statistically significant. (Fig.1D ), which was in agreement with previous report (34). OBRa was expressed in most NIT cells, OBRb and Isl-1 were well expressed in all NIT cells (Fig.1D ), which suggest that NIT cells can be as a cell model to investigate potential molecular crosstalk between leptin and Isl-1.
RESULTS
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Leptin suppresses Isl-1 expression and insulin secretion in vitro and in vivo-
To identify the functional relationship between leptin and Isl-1 in regulating insulin level, the cultured NIT cells were treated with 0 (control), 1, 10 and 100 ng/ml leptin for 3 h in 16.5 mM glucose medium, and the Isl-1 mRNA level in the cultured cells and insulin level in the culture medium were analyzed. The results firstly demonstrated that leptin sharply decreased Isl-1 gene expression ( Fig.2A, P<0 .01) and insulin secretion (Fig.2B , P<0.05) in NIT cells, although there was no significant leptin dose dependence. In addition, we administered 0.5 mg/kg leptin in 200 μl volume to the mouse via a caudal vein injection, and Isl-1 mRNA and protein levels in the pancreas were detected at 0.5, 3 and 6 h, respectively. The results showed that leptin significantly decreased pancreatic Isl-1 mRNA level at 0.5 h, and this persisted until 6 h (Fig.2C,  P<0 .01). However, pancreatic Isl-1 protein level by Western blot and insulin level significantly declined at 3 h, followed by a sharp decrease at 6 h ( Fig.2D and 2E ).
As HFD significantly increases leptin levels in serum (27-28), we thus checked the effects of leptin on Isl-1 expression and insulin level by dietary manipulation. The results showed that the HFD significantly increased serum leptin level compared to the control and fast groups after 24 h treatment (Fig.2F , P<0.05) as we expected. The increase in serum leptin levels induced by HFD was associated with a significant decrease in the mRNA and protein levels of Isl-1 ( Fig.2H and 2I) and serum insulin (Fig.2G, P<0 ), and the results showed that the targeted deletion of Isl-1 mRNA level in exon 3/4 decreased by 67.6% in the IKO mice pancreas (Fig.3A, P<0 .01). Similar to the change of Isl-1 gene expression, the pancreatic Isl-1 protein level in IKO mice was significantly lower than the control by Western blot (Fig.3B) . Immunofluorescence results (Fig.3C) showed that fluorescence intensity was much weaker and the percentage of Isl-1 positive cell number accounting for the total pancreatic islet cell number was obviously lower in IKO mice. In addition, we isolated pancreatic islets from IKO and control mice (Fig.3E) as described by Li et al (32), and also knocked down Isl-1 in vitro in floxed mice by 4-OH tamoxifen-induced Cre expression for 48 h before the collection of the pancreatic islets according to the method reported (35). Isl-1 gene expressions in islets from IKO mice and control mice were detected by RT-PCR. The results showed that Isl-1 mRNA in exon 3/4 decreased by 76.3% in IKO mice compared with the controls (Fig.3F,  P<0 .01). These indicate that Isl-1 excision is efficient by Cre both in vivo and in vitro.
In order to identify whether the effect of leptin on insulin secretion was mediated by Isl-1, 0.5 mg/kg leptin was administered to the IKO and control mice via a caudal vein injection, respectively. After 6 h, leptin induced a 37.3% decrease in serum insulin level in the control mice, but leptin had no significant effect on insulin level in IKO mice (Fig.3D, P<0.05 ). In the cultured islet cells from control mice, 10 ng/ml leptin decreased the insulin level by 43.8% after 3 h treatment, but there is no significant effect in IKO islets (Fig.3G, P<0.05 ). These findings demonstrate that the regulating effect of leptin on insulin secretion is at least partly mediated by Isl-1 supporting our hypothesis.
Effects of leptin on Isl-1 expression and insulin secretion depend on leptin receptor and JAK-STAT3 pathway-In order to answer what is the signaling pathway utilized by leptin in regulating Isl-1 expression and insulin secretion, we used the db/db mice (36), and firstly analyzed and compared pancreatic Isl-1 gene expression and serum insulin level in the db/db and db/+ mice. The results showed that the Isl-1 mRNA and insulin level were significantly higher in db/db mice than the db/+ mice ( Fig.4A and 4B , P<0.01). Subsequently, 0.5 mg/kg leptin was administered to db/db mice via a caudal vein injection. After 0.5, 3 and 6 h, pancreas Isl-1 expression and serum insulin level were measured. The results showed that leptin did not affect Isl-1 expression either at gene or protein levels, and had no effect on serum insulin level at any time point examined in db/db mice, compared with saline injected and control in db/db mice (Fig.4C, 4D and 4E ). These demonstrate that the effects of leptin on Isl-1 expression and insulin secretion require expression of the OBR.
Leptin and its receptors signaling is transducted through multiple pathways, including PI3K (37), JAK-STAT3 and ERK pathways (9). In order to determine the downstream signaling of leptin affecting Isl-1 expression and insulin secretion, NIT cells were treated with 10 ng/ml leptin for 0, 5, 10, 20 and 30 min, the phosphorylated STAT3 and phosphorylated ERK were analyzed by Western blot. The results showed that the leptin significantly increased the p-STAT3 level after 5 min exposure and persisted until 30 min, but it had no obvious influence on ERK activity at any time examined (Fig.4F) . Further, the ERK1/2 antagonist PD98059, JAK-selective tyrosine kinase inhibitor AG490, PI3K inhibitor LY or the STAT3 phosphorylation suppressor PTL was respectively added to the cultured NIT cells for 1 h before addition of leptin for 3 h. The results showed that the decline of Isl-1 mRNA levels induced by leptin were blocked by both JAK-STAT3 pathway inhibitors AG490 and PTL, the decrease of insulin mRNA levels induced by leptin were blocked by AG490, PTL and LY. It is in contrast that the ERK inhibitor PD98059 did not influence the Isl-1 mRNA and insulin levels induced by leptin (Fig.4G, P<0.05 (Fig.5A, P<0.01) .
To (Fig.5B) . Using DNA fragments precipitated with anti-p-STAT3 as templates, eight pairs of primers were designed to amplify the regions containing each of the putative STAT3 binding sites (Table 1) . Of these eight putative STAT3 binding sites in the Isl-1 promoter, only one region from -1262 to -1143 bp, was found to be occupied by phosphorylated STAT3 protein (Fig.5C ). This result was confirmed by real-time PCR and the comparison with the relevant input DNA (Fig.5D ). These data firstly indicate that the functional STAT3 directly binds to Isl-1 gene promoter.
To determine whether STAT3 is involved in regulating Isl-1 gene transcription, the vectors encoding wide-type STAT3 and mutant STAT3C were transfected into NIT and 293T cells with Isl-1 promoter-luciferase genes. A dual-luciferase reporter assay showed that STAT3C inhibited Isl-1 promoter activity about 0.42 fold (Fig.5E, P<0 .01) in 293T cells and 0.68 fold (Fig.5F, P<0 .05) in NIT cells respectively. However, STAT3 overexpression did not change the luciferase activity of pGL3.0. Our results firstly show that the p-STAT3 exerts an inhibitory effect on Isl-1 promoter activity.
In order to determine if Isl-1 is involved in regulating insulin gene transcription, pXJ40-Myc-Isl-1 (41) was transfected into 293T cells and NIT cells with insulin promoter-luciferase vectors. Dual-luciferase reporter assay showed that Isl-1 enhanced the activities of -410 insulin about 27 fold in 293T cells (Fig.5G, P<0 .01) and 4.7 fold in NIT cells (Fig.5H, 
P<0.01).
In contrast, Isl-1 overexpression did not change the luciferase activity of pGL3.0-basic control vector. These results are in agreement with the previous reports (7) that Isl-1 influence insulin level through enhancing insulin promoter activity.
Insulin has feedback effects on Isl-1 gene expression through JAK-STAT3 signaling pathway-In order to identify whether insulin had the feedback regulating effects on Isl-1 expression and insulin secretion, and if the downstream signals of both leptin and insulin transduced through the same transcription factors STAT3 and Isl-1, the cultured NIT cells were treated with 10 -8 M insulin in DMEM with 16.5 mM glucose medium for 12 h. The RT-PCR results showed that insulin significantly decreased the mRNA levels of Isl-1 and insulin receptor, but had no effect on leptin receptor expression ( Fig.6A and 6B , P<0.05). Further, NIT cells were exposed to insulin for 6, 12 and 24 h, Isl-1 protein levels were analyzed by Western blot. The results showed that the insulin significantly decreased the Isl-1 protein levels after 12 h exposure and persisted until 24 h (Fig.6C, P<0 .01). In order to determine if STAT3 is involved in the regulation of Isl-1 expression by insulin, AG490 and PTL were added to the cultured cells, before treatment with insulin as above. The RT-PCR results showed that both AG490 and PTL treatments blocked the effects of insulin on Isl-1 expression (Fig.6B The present study has demonstrated the effects of leptin on Isl-1 expression and insulin secretion depend on leptin receptor and through JAK-STAT3 pathway. There are evidence that leptin directly acts on the ATP-sensitive potassium channels to hyperpolarize the beta cell and lower the [Ca 2+ ]i (4) (as shown in Fig.7 ). In addition, there are reports that leptin binds to its full-length receptor, OBRb, to activate the JAK-STAT3 pathway in pancreatic islets (9). Our results here show that the inhibiting effects of leptin on Isl-1 expression and insulin secretion miss in defective db/db mice model. Moreover, in vitro experiment results prove that the downstream pathway of leptin affecting Isl-1 expression relys on JAK-STAT3, but not through ERK1/2 and PI3K. This is supported by our recent report that leptin affects Isl-1 expression by STAT3 transcription factor in pituitary gonadotropes (29).
It has been reported that STAT3 functions as a transcriptional activator, or as a transcriptional inhibitor by its interacting with other transcription factors and/or co-activators/co-repressors, depending on the target promoter (47). Whereas Isl-1 not only forms a complex with JAK1 and STAT3 but also triggers the tyrosine phosphorylation of JAK and its kinase activity to elevate the tyrosine phosphorylation, DNA binding activity, and targets gene expression of STAT3 (41). However, it had not been established about the interacting mechanism between leptin signaling molecule STAT3 and Isl-1. The results here indicate that the overexpression of STAT3C significantly decreases the Isl-1 mRNA level compared to the wild-type STAT3. In addition, our CHIP and Luc assay results indicate that Isl-1 is a direct downstream target of STAT3, the phosphorlated STAT3 binds to the Isl-1 gene promoter, inhibits the activity of Isl-1 promoter, and subsequently decreases insulin synthesis and secretion. These findings thus link STAT3 signaling directly with the Isl-1 axis, and this novel signaling pathway of leptin affecting insulin secretion (as shown in Fig.7) provides us the potential molecular targets for intervening insulin secretion for physiology and/or pathology.
Isl-1 mediates the regulating effect of leptin on insulin secretion through OBR and JAK-STAT3 signaling pathway as showed here, but insulin in turn plays a role as an autocrine/paracrine molecule to balance pancreatic hormones secretion (48-49). In addition, insulin has anti-apoptotic as well as enhancing proliferation effects on beta cells of islets (50). In order to assess whether the feedback regulating effect on islets beta cells is through transcriptional factor Isl-1, we checked the changes of Isl-1 expression after the cultured NIT cells were treated with insulin, and the results showed that insulin significantly decreased the insulin receptor and Isl-1 gene expressions. Further, to determine if insulin and its receptor signaling to regulate Isl-1 expression is through STAT3, the JAK-selective tyrosine kinase and STATs were respectively blocked by using AG490 and PTL. The results showed that the decrease in Isl-1 expression induced by insulin was blocked after both AG490 and PTL treatments. These indicate that STAT3 and Isl-1 are the keynote proteins linking the leptin and insulin signaling networks in regulating insulin secretion.
In conclusion, the present study shows a unique interaction between leptin signaling and the transcriptional factor Isl-1, and the insulin secretion is regulated by their interactions. Furthermore, the auto-feedback effects of insulin appear to act by also regulating effect on Isl-1 expression. In addition to the essential role of glucose in regulating insulin secretion, there is also a balance between the effects of insulin and leptin which also modulates insulin output. These findings are crucial for understanding the mechanisms regulating insulin secretion and metabolism in related diseases, such as obesity and type 2 diabetes. ]i and inhibits insulin secretion. The extracellular insulin binds to its receptor and undergoes autophosphorylation, this activates JAK2, leading to recruitment and activation of STAT3, activated STAT3 subsequently inhibits Isl-1 expression and insulin secretion. These indicate that STAT3 and Isl-1 are the keynote proteins linking the leptin and insulin signaling networks in regulating insulin secretion. JAK, janus kinase; STAT, signal transducers and activators of transcription; VDCC, voltage-dependent calcium channels. Table 1 Primers'name and sequence 
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